Pharmacogenetics of the Glucagon-like Peptide-1 Receptor Agonist Liraglutide: A Step Towards Personalized Type 2 Diabetes Management. Επικοινωνία Submitted by Δημήτριος Γουλής on Κυρ, 08/07/2022 - 22:32
